35 ms·
Vaccine hopes rise as Oxford jab prompts immune response among old and young
- marketingPro 6y agoThis article reinforces that herd immunity between young healthy people would have been the best solution. Our old are going to get sick from vaccines, so the young are going to get it anyway. Next year under 50 year olds will line up for their vaccine. Meanwhile 1.5 years worth of old, obese, and sick people will have died from coronavirus. Wouldn't it have been better if healthy kids and adults caught it in q2 2020? (Please no ancedotes of a sick 5 year old child dying from "coronavirus", statistics are necessary when discussing billions)
- glotgizmo 6y ago(In the UK) Young healthy adults and kids live with old/unhealthy/frail parents due to the enormous financial difficulty of leaving home.
- jedimastert 6y agoAnd in the US too
- henearkr 6y agoThis is a virus with bad long-term effects on the body. Not a good idea to catch it just to get immune.
- rimliu 6y agoNobody knows its long term effect on the body. Especially if you were asymptomatic.
- feanaro 6y agoYour response is phrased in a way that all the meaning lies in the exact definition of what you mean by "knows". There is certainly evidence that there are long-term effects. Example: https://www.medrxiv.org/content/10.1101/2020.10.20.20215863v1 https://www.medrxiv.org/content/10.1101/2020.10.20.20215863v...
- henearkr 6y agoThis huge uncertainty is in favor of avoiding taking the risks, rather than the other way.
- anoncake 6y agoPut another way: Nobody knows of any long term effect on the body.
- cheph 6y ago> This is a virus with bad long-term effects on the body. In what percentage of people who get COVID-19 are there bad long-term effects? What other conditions did the people get bad long term effects have? How does these numbers compare with other diseases? Would appreciate citations.
- 3np 6y agoWe don't know. Which is why it's preferred to play it safe, in that regard.
- henearkr 6y agoDamage to the heart, the brain, even for mild or asymptotic cases. My references are previous posts on HN or on phys.org as you can easily search it. As you said there are scarce data yet, but the risks are scary. In these conditions, it's obvious one should avoid relying on a herd immunity induced by the virus.
- cheph 6y ago> My references are previous posts on HN or on phys.org as you can easily search it. And you could cite a claim you are making. Without numbers it is hard to say if this is a good basis for decisions.
- henearkr 6y agoThe statistics are in the making, and researchers discover more illness mechanisms each day. As I said, we are in the presence of a huge risk and there is no "reassuring numbers" anywhere to counterbalance that. As one reference on the risks I'm speaking of, here is an article about the action of the virus on the nerve cells: https://www.scientificamerican.com/article/what-we-know-so-far-about-how-covid-affects-the-nervous-system/ https://www.scientificamerican.com/article/what-we-know-so-f... By the way, between "relying on virus-induced herd immunity" and just keeping safe with mask and waiting for the vaccine to come, why the rush to get the virus?? There is a risk, there is the possibility to wait it over. So why just not do that and wait the safe solution?
- celticninja 6y agoGiven that immunity from infection is currently questionable your suggestion doesn't make sense. The reason the findings mentioned in this article are important is because the immune response seems to be stronger than that seen in people that have been infected and recovered. So this vaccine would be better at creating herd immunity than just allowing everyone to get infected. At the same time vaccinations will have a reduced impact on people than actually catching the virus would. There is a difference between the level of illness experienced by those who are vaccinated Vs those who get infected, so more old people will die as a result of infection than would die as a result of vaccination. So no, it would not be better for healthy adults and kids to get it in Q2 2020. Also how do you propose that you only infect the healthy adults and kids?
- rimliu 6y agoHow is immunity from infection questionable? We had 43 million cases and about a dozen or so reinfections. Not sure if confirmed reinfections reach the double digits yet.
- graeme 6y agoSo studies of other coronaviruses show immunity lasted 6-12 months. We’re a but early to see mass reinfections. That said, my guess would be normal reinfections would be less severe, more like a cold. There have been some severe reinfections but any reinfection under six months suggests something atypical in the immune response. Also SARS-Cov-1 produced a longer immune response so that may happen here. But lifelong sterilizing immunity seems pretty unlikely based on what we know so far. The vaccines aren’t aiming at sterilizing immunity actually, their goal is to greatly lower the severity of the infection.
- rimliu 6y agoStudies also show that the immunity for original SARS (the close relative) lasts many years.
- 6y ago
- LatteLazy 6y agoWhy would old people get sick from the vaccine? If we let everyone get it in Q2 2020, millions would have died when we ran out of ventilators.
- mav3rick 6y agoNot supporting the OP's assertions, but vaccines have some timid / less potent form of the virus.
- roman030 6y agoImagine throwing your phone at the wall and it shatters into 1000 pieces. Now try calling someone with one of these pieces.
- ourcat 6y agoA certain amount of 'reactogenicity' is expected with most vaccines. ie: "expected" adverse reactions.
- LatteLazy 6y agoThanks, I guess people do get mild flu after the flu vaccine so it would make sense for it to be the same.
- toolz 6y agoThe implication that we even slowed the trajectory isn't well established. It's likely, but not proven. Let's not get ahead of ourselves by pretending there's evidence millions would have died when there's not even a strong correlation between mandates (as defined by the Oxford stringency index database) and reduced death. and nowhere that I'm aware of came close to running out of ventilators. New York, one of the hardest hit places in the world may have used a third of their available ventilators. They used around 1/2 of the ventilators they reported available to them in 2015 so it wasn't even close to being the limiting factor in healthcare.
- umanwizard 6y ago> If we let everyone get it in Q2 2020, millions would have died when we ran out of ventilators. How do you explain countries like Belarus, Serbia and Sweden, or parts of the US like South Dakota, where no or very lax measures were taken but what you describe didn’t happen? In fact, is there any evidence that this happened anywhere, or is it all just conjecture based on modeling?
- lazzurs 6y agoIt’s super easy to make those decisions as an abstract mathematical problem. It is another when someone puts your family in front of you and asks you to roll the dice. As an abstract mathematical problem if somehow herd immunity could be achieved without a vaccine then it sounds like a fine idea. The fact is that immunity after infection does not last long enough to achieve significant enough immunity to get to a useful herd immunity. This of course is what all the medical experts understand which is why Europe is going through lockdowns and Putin has been hiding in a bunker. There have been strict lockdowns in China and most other major governments have taken some sort of similar response, even Sweden eventually. There is almost nothing all of these governments have ever agreed on so universally. Don’t expect a reply justifying my comment on HN with robust data, I have better things to do with my time like play in a park.
- im3w1l 6y agoI was considering bug chasing and then isolating. I regret not doing so.
- gnfargbl 6y agoThat option was apparently actively considered by the UK Government's scientific advisory group, but rejected on the basis that it would not actually be possible to prevent transmission from less-vulnerable groups to more-vulnerable groups. Reference: https://archive.is/43ir5 https://archive.is/43ir5
- jmull 6y ago> Wouldn't it have been better if healthy kids and adults caught it in q2 2020? No. We have one population. There's no way to segment it to allow people at low risk to catch the virus without also allowing people at high risk to get it. How do you think it could work otherwise?
- dbetteridge 6y agoOK, someone tell me why this isn't the good news it sounds like
- kalaido 6y agoYou mean because of the 2 deaths?
- henearkr 6y agoThis IS good news. Now (soon, hopefully) people can acquire immunity through a vaccine, instead of through a virus that leaves long-lasting damage to the body (in particular, but not limited to, the brain).
- singemonkey 6y agoAs well as acquiring immunity without being infectious. However, the efficacy of this vaccine (and all the other candidates) still needs to be clarified - ie is it like a measles vaccination (~90% efficacy) or the flu vaccines (~ 25% - 50% I believe).
- viraptor 6y agoSounds right for the flu. I was curious about the details - here's a good starting point. https://www.cdc.gov/flu/vaccines-work/vaccineeffect.htm?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fflu%2Fprevent%2Fvaccineeffect.htm#doe_flu_vax_effect_vary_by_type_subtype https://www.cdc.gov/flu/vaccines-work/vaccineeffect.htm?CDC_...
- lbeltrame 6y agoFor the FDA to even consider an emergency use authorization, they have put the following requirements: - Efficacy of at least 60% - Lower bound of efficacy (confidence interval) >= 30% - Minimum safety data for at least one or two months post vaccination (I don't remember if it's one or two) - At least five severe cases in the control arm - Requirements for the trials to go on even if efficacy is found for an additional year after the trial end (for most of the trials, this means two years in total)
- godelmachine 6y agoIs this not the one they will launch in India first? Edit1: Just to throw in more info, Oxford plans to scale this up for mass production with Serum Institute of India and AstraZeneca.
- sanketskasar 6y agoIt is the same. But you cannot expect a vaccine to work similarly in people of two different regions having major differences in their diet, climate and lifestyles. That's why many vaccine candidates are being tested in multiple countries( read potential markets). Also, I think the UK has preferential rights at least on the initial yield of the vaccine.
- threeseed 6y agoAstraZeneca is licensing the "recipe" for the vaccine to other countries so yield won't be an issue. Australia is part of this group that will be manufacturing all the dosages locally and independently.
- geuis 6y agoI don’t think you understand how the biology of vaccines work.
- hn_throwaway_99 6y ago> But you cannot expect a vaccine to work similarly in people of two different regions having major differences in their diet, climate and lifestyles. Can you? Do you have any examples of successful vaccines that are only given in one region because they have been proven ineffective in a different region?
- throwaway4good 6y agoAll these hundreds of vaccines that are being developed; are they all triggering the same immune response?
- wcoenen 6y agoOne vaccine doesn't even trigger the same immune response in different people, so it is not entirely clear to me what you mean. The basic principle of a vaccine is that it contains proteins that are the same as (or similar to) some of the protein building blocks of the actual virus. Your body learns an immune response to these proteins, which it can reactivate when it encounters the real thing. Many potential vaccines target the same spike proteins on the outside of the virus. I guess you could say those produce "the same immune response" in that sense.
- throwaway4good 6y agoIt was in the latter sense.
- jonathanstrange 6y agoNo. AFAIK, they may target different proteins on the virus hull and also differ in other respects among each other. Some of them might be less effective than others, some might be more prone to being rendered ineffective by virus mutations than others, there can be substantial differences in the number of complications caused by vaccination, and some of them could also cause problems with developing future vaccines for deadly coronavirus variants that may occur another time. At least, that's how I understand it from what I've heard. Others should please correct me if I'm wrong.
- coldpie 6y agoBack in May, Ars Technica did a really great overview of how each of the various types of vaccines work. It's very much worth reading. https://arstechnica.com/science/2020/05/the-ars-covid-19-vaccine-primer-100-plus-in-the-works-8-in-clinical-trials/ https://arstechnica.com/science/2020/05/the-ars-covid-19-vac...
- lbeltrame 6y ago
- ageitgey 6y agoA quick summary of were the Oxford vaccine stands since it's hard to follow: - When will the vaccine be ready? After the Phase 3 efficacy data is reported, assuming that the data shows that the vaccine prevents COVID or reduces COVID severity. This happens after enough people in the trial get sick with COVID. Then they unblind the groups and see if the people who got sick were in the control group or the vaccinated group. Essentially we are all waiting for a few 10s of people to get COVID. You can guess that the UK, South Africa and Brazil trials are getting very close to this since those trials have been running for months, but the US trial has recently started and is being run separately and wouldn't be very close yet. So the UK would probably have the first chance of approving this vaccine. - What do we know about vaccine effectiveness so far? So far, they've published initial safety data and immune response data in both healthy young adults and now in older adults. That all looks good - basically, the vaccine generates a lot of antibodies in everyone who takes it. So in theory, it should work. Separately, other groups have done testing to verify that the vaccine is operating the way it should at a biological level. There were also very early animal tests to show that the vaccine reduced the severity of COVID and prevented serve lung symptoms. In those tests, the vaccine didn't totally prevent transmission, but the animals were injected with a large amount of virus and it's not clear how humans will react in the real world (hence the wait for Phase 3 trail results). - If it works, how long would immunity last? No one knows until we wait and find out. But people vaccinated with the experimental SARS-1 vaccine still show antibodies over 10 years later, so the hope is that it could be long lasting. - Didn't they have to stop this trial at one point because someone got sick? Actually, at least 3 adverse events have occurred. Early on, one person got symptoms consistent with typical vaccine side effects, but it was determined that the person had a previously undiagnosed, unrelated disease. Second, there was the highly publicized case where a patient suffered temporary spinal inflammation and recovered shortly. It is unclear if this event is related to the vaccine, but trials in all countries have resumed so the various government agencies seem satisfied. Third, a patient in Brazil died of COVID but it was reported that the patient was in the control group and hadn't received the vaccine. Very little information from these cases is reported because of health privacy laws, so some of this information comes from media reports as opposed to official announcements. None of it seems inconsistent with a normal vaccine trial. - Would you feel comfortable taking it yourself? Yes, I did (I'm in the trial). No side effects worse than a flu shot personally.
- cesarb 6y agoTo us in Brazil, this vaccine is particularly interesting because not only is it one of the vaccines being tested here (together with FIOCRUZ in Rio de Janeiro; another one is Coronavac from Sinovac together with Instituto Butantan in São Paulo), but also there's already an agreement to manufacture it in the country (https://portal.fiocruz.br/noticia/fiocruz-assina-contrato-de-100-milhoes-de-doses-da-vacina https://portal.fiocruz.br/noticia/fiocruz-assina-contrato-de...).
- FailMore 6y agoWHOOOOOOOOOOOOOOO HOOOOOOOOOOOOOOO
- fallingfrog 6y agoBet you they give it to everyone for free everywhere in the world except for the USA, where they charge 600 dollars a dose and consequently we never reach herd immunity and have endemic Covid indefinitely.
- hans1729 6y ago800 for the dose, 300 for a list of other things on the bill, and you're required by law to get the injection today. if you can't afford it, that's prison time, where you'll get the vaccinee but also need to work for the bill, probably producing maga-caps or substituting sick/dead medical personnel. eagle screeches are we there yet?
- dang 6y agoWould you please stop posting flamebait to HN and not use the site primarily for ideological battle? We ban accounts that do those things and have already had to ask you a few times. https://news.ycombinator.com/newsguidelines.html https://news.ycombinator.com/newsguidelines.html
- fallingfrog 6y agoI’m genuinely surprised.. Does this comment really read as flamebait? The article is about vaccines. A vaccine has to be administered to everyone to work. But I’m very skeptical that it’s actually going to happen given the way our medical system works here. So, I predict that there’s a good chance we won’t get herd immunity. I just don’t see how that’s flamebait. It’s more, known facts and extrapolation.
- pvg 6y agoknown facts You can look up the moderator commentary on 'facts' and flamebait (tldr is, you can flamebait with facts) but these aren't even facts - free vaccine has been the stated official plan in the US for months.
- dang 6y agoSure it does. This may be a case of "comments in the rear view mirror are much larger than they appear", i.e. people underestimate how provocative their posts are. US healthcare differences are a classic flamewar topic and nationalistic flamewar is particularly ugly and pointless. Your comment wasn't thoughtful/substantive, it was snarky/hyperbolic. Ergo flamebait.
- Bobblebobble 6y agoI'm in the trial. Here's the participant information sheet, in case anyone's curious: https://drive.google.com/file/d/1WB5QPmECchlThnem9wcX0PDaKQWtmUgZ/view?usp=sharing https://drive.google.com/file/d/1WB5QPmECchlThnem9wcX0PDaKQW...
- mromanuk 6y agoat what point you know (or will know) if you were given a placebo or the actual vaccine?
- garmaine 6y agowhen the trial is ended.
- xxs 6y ago...or in this case if you get infected with the real thing as medical history is important.
- Bobblebobble 6y agoAt the end of the study.
- erikrothoff 6y agoAre you given any monetary compensation or compensation at all for joining the trial?
- Bobblebobble 6y agoYes, they pay a small amount and cover travel expenses.
- eznzt 6y agoFrom TFPDF: >You will be compensated for your time, the inconvenience of having blood tests and procedures, and your travel expenses. The total amount compensated will be approximately £235 - £625 depending on the exact number of visits and whether any repeat or additional visits are necessary.
- nbevans 6y agoOne interesting point that I read about the Oxford vaccine is that it only needs chilling to -5c. Whereas many of the other vaccines (I don't know if all others or just some) need chilling to -60c. It strikes me that the Oxford vaccine has a distinct advantage when it comes to global distribution.
- lbeltrame 6y agoRNA vaccines (Pfizer, Moderna) require storage at -80C, because RNA is a molecule that can degrade easily at higher temperature. Other vaccines can be stored at -20C, usually.
- dblooman 6y agoNot knowing anything about big pharma, does Astrazeneca make all the money here? How much does a vaccine like this cost per person given the scale of the distribution and manufacturing?
- lettergram 6y agoUsually there is an IP agreement. Also, ever notice the media calls it “Oxford study/vaccine” for good news and “Astrazeneca study/vaccine” when it’s bad news (like a few weeks ago when they had to shutdown to multiple people getting an unknown illness). I work in an area where we make agreements with university’s. It’s often shared IP or publicity. Alternatively, one can publish, once the other makes profits. Or it could be something in between. In this case, I bet everyone is doing this pro-Bono from a future profit perspective, because the government is paying for all of it.
- lbeltrame 6y agoIIRC, the expected price is around $3.50/dose, but I can't find the source for that anymore. AZ and Oxford have pledged not to ask for royalties or whatever, at least until the pandemic is ongoing (that would likely mean all of 2021 at the earliest).
- zoobab 6y agoGood news for US BigPharma Merck holding the Oxford patents, while public funding has paid for its research: https://archive.is/aGUJd https://archive.is/aGUJd
- rolivercoffee 6y agoI was under the impression there was an exclusive agreement in place with AstraZeneca but the general terms for access to Oxford's IP was: https://innovation.ox.ac.uk/technologies-available/technology-licensing/expedited-access-covid-19-related-ip/ https://innovation.ox.ac.uk/technologies-available/technolog...
- apexalpha 6y agoWho cares. I'd gladly give this company a couple of billion if it means they can get us back to normal. Oxford develops the vaccine with public money. We also, god willing, need to manufacture billions of them and transport them around the globe. For that manufacturing, give me a solid existing multinational with a proven manufacturing record and base please, not some non-profit startup.
- alxlaz 6y ago> not some non-profit startup. There's no(t necessarily a) question of any non-profit startup there. The problem is that the people who paid for the development of the product should also hold rights over the product. If the vaccine was developed with public money, it should be publicly available -- not necessarily (but yes, also to) non-profit startups, but also to any other manufacturer in the pharmaceutical industry, since they (allegedly, in any case...) pay taxes, too, and have therefore invested in this product. If Merck wants to use their proven manufacturing base with an excellent delivery track record (which nobody is denying, after all), that's great. They can: 1. Put their money into the development of said vaccine, or 2. Acquire the license to manufacture it, at a reasonable price, like they do with any technology that wasn't developed using public money, or 3. If we don't want stuff that's already been paid for with public money to be sold to manufacturers, which I don't disagree with at all, then, sure, they should get it for free -- but in that case they shouldn't be the sole owner of the rights towards that product, either. (Edit: FWIW, I'm all for 3. I've worked in the medical industry and I know full well that there's a great deal of work that goes between first-stage research and final production, and that it's incredibly hard and expensive to take the result of a publicly-funded research program and turn it into a product. That doesn't change the fact that said research programs are publicly-funded -- their results should be available to anyone who paid for them. If someone wants exclusive rights to the result of some research program, then they're welcome to pay for it themselves.) As it stands now, they own the rights (including licensing rights!) to a bunch of products that they haven't paid for at all. All the suits blabber on and on and on about how the government should keep its nose out of their business. How about they tell the government where to stick it when it's about paying for their research, too?
- nickcotter 6y agoGood news but still a long way to go. How's it going to be rolled out? Here in the UK we have tried and failed to get a regular flu jab (our GPs have run out of a very small supply and the pharmacies don't have any to sell) and I'm not optimistic about our chances of getting this next year or whenever it arrives.
- d0ugal 6y agoI was able to get the flu jab easily in Scotland (as was my wife and my daughter is getting it tomorrow). It was incredibly well organised. I think if you are unlucky it can be hard to get, but it is rolling out fast and many people are thankfully able to get it.
- benlumen 6y agoI think you might be surprised. The government knows that this is the silver bullet they need to rescue the economy from oblivion. I’m expecting that once this thing is ready there’ll be a logistical effort for the history books to roll it out. See what they can do with the military involved, like the nightingales.
- cmrdporcupine 6y agoSad to say, given how testing, lockdown, etc. has proceeded, I'm losing confidence that most western governments are capable of any "logistical efforts for the history books" at this point. I heard a lot of bluster about testing here in Ontario in the spring, but here we are in the fall with rationing of tests again.
- mikepurvis 6y agoTesting in Waterloo Region was really good over the summer— minimal wait times, multiple drive-in sites, results turned around in 24-36hrs. I think they just failed to account for the bump that would come from school starting and people wanting to get tested in advance of Thanksgiving. I think the "military involved" piece is key, especially if you're talking about the US. It's maybe a bit trite at this point, but a lot of comparisons were made about the stark contrast in how quickly a national response mobilized in response to BLM protests vs the pandemic. The basic takeaway being: executive priorities matter, and even Trump has made it clear on a number of occasions that getting the vaccine out is important to him.
- curiousllama 6y agoThe good ol' Oxford Jab
- barbecue_sauce 6y agoVery awkward use of informal english in this article's title, particularly from Reuters.
- ageitgey 6y agoThe word jab is standard UK English for 'shot'. It might be slightly informal, but it's definitely standard to see it in the news and in government publications. Example: https://www.bbc.co.uk/news/health-54337585 https://www.bbc.co.uk/news/health-54337585
- deleted 6y ago[deleted]
- digitalice 6y agoCorrect me if I'm wrong, but isn't this the vaccine that killed a test subject? https://www.nbcnews.com/health/health-news/volunteer-astrazeneca-covid-19-vaccine-trial-dies-brazil-n1244166 https://www.nbcnews.com/health/health-news/volunteer-astraze...
- dtech 6y agoA person who got the vaccine died; "vaccine killed a test subject" is quite misleading.
- Fragoel2 6y agoUnfortunately that's how most newspapers released the news, so I'm not surprised he's confused
- digitalice 6y agoMaybe yes, but this is the second time there is trouble with this specific vaccine.
- digitalice 6y agoRight, further investigation is needed, but how about this one: https://edition.cnn.com/2020/09/17/health/astrazeneca-vaccine-trial-document/index.html https://edition.cnn.com/2020/09/17/health/astrazeneca-vaccin...
- cesarb 6y agoWhat has been reported in the local media, is that the doctor who died did not get the vaccine. He was one of the test subjects, but half of the test subjects receive a placebo instead of the vaccine (the whole point of the experiment is to see how the vaccine compares with a placebo); he was in the group that received the placebo.
- ageitgey 6y agoNo, that's completely wrong. The person who died was in the control group: https://www.bbc.co.uk/news/world-latin-america-54634518 https://www.bbc.co.uk/news/world-latin-america-54634518 They don't release more details officially due to patient confidentiality, but the unofficial word was that a young doctor treating COVID patients died of COVID during the trial, but was in the control group and did not receive the vaccine. It is very sad whenever a doctor dies trying to save others, but especially because they may still be alive if they had been randomized to the vaccination group (of course we don't know that for sure though, since the vaccine may still prove to be effective or ineffective).
- White_Wolf 6y agoAre the full results of the human trials available anywhere?
- blackbear_ 6y agoHere [1]. It will be updated with the results, eventually. [1]: https://clinicaltrials.gov/ct2/show/study/NCT04516746 https://clinicaltrials.gov/ct2/show/study/NCT04516746
- sabersei2 6y agoMehhhhhhhhh
- covid-69 6y agoSo who will actually get the vaccine? Not me.
- neilwilson 6y agoThose who are scared of the consequences of catching Covid I guess, and there are plenty of those. Once volunteer is worth ten pressed men as they say.
- qwerty1234599 6y agoAdmit it, you're just subconciously afraid of needles as most people. Noticed it with Trump. No way he'd take an experimental COVID vaccine, but an experimental antibody drug cocktail through the mouth was more than ok to him. Pro tip: it all ends up in the bloodstream in the end.
- deleted 6y ago[deleted]
- tim333 6y agoI don't much like needles. I'm thinking the Bharat Biotech nasal vaccine is the way to go. https://indianexpress.com/article/india/bharat-biotech-to-manufacture-a-billion-doses-of-nasal-spray-covid-19-vaccine-6607305/ https://indianexpress.com/article/india/bharat-biotech-to-ma...
- IgorPartola 6y agoNo worries. I don’t think it works on trolls.
- aokiji 6y agoI hope that by coincidence, the vaccines do not magically get safety approval after the day of the United States' elections.
- maxehmookau 6y agoI'm in the trial. It's really exciting, not least because form a purely selfish point of view, I might be immune already! ...or not. But it's exciting either way! AMA?
- xwdv 6y agoWhat if something goes horribly wrong and the vaccine trial causes unwanted side effects? Why risk it, what are they paying you?
- maxehmookau 6y agoI'm receiving no money for my participation. I wasn't in the initial Phase I trial, a few hundred people had already received the vaccine before me with no unexpected side effects. I guess I'm risking it because someone has to. Vaccine trials are incredibly safe and highly regulated. In reality, the worst-case was that it didn't work rather than my head exploding.
- xwdv 6y agoHow do you prove to people you are in a vaccine trial, do you have a card?
- maxehmookau 6y agoI have a "red alert" card so if I'm found unconscious a paramedic knows to contact the study team to find out if I'm in the control arm or I've had the active vaccine so they can rule out if it's important to why I was found unconscious! But it is just a piece of paper that the team printed out, and I think I lost it.
- neuronic 6y agoParamedics won't go through your wallet anyways.
- 6y ago
- 02020202 6y agoyou can take your vaccine and shove it up... you know where.
- whycombagator 6y agoMaybe I missed it in the article but it appears to me this is just a spokesperson saying things, not actual data or results.
- hikerclimber 6y agohopefully this doesn't work.
- cwhiz 6y agoCan someone explain to me why double blind is necessary or useful for a vaccine trial such as this? It seems obvious to me on something like a pain medicine, but on a vaccine it seem a pointless. Is placebo an actual issue with a vaccine? It honestly seems borderline unethical to give people a placebo vaccine.
- keyme 6y agoPlacebo can have an effect on side effects.
- cwhiz 6y agoAre they testing for side effects in all three stages? I thought the first two trials were for safety and the third was for efficacy. Is that incorrect?
- tcoff91 6y agoThey're absolutely monitoring side effects during phase 3. some safety effects can be rare enough that they don't show up in phase 1/2.
- cwhiz 6y agoOkay. I’m still having a hard time understanding how placebo helps them test for side effects.
- Izkata 6y agoI imagine: If a given side-effect occurs at the same rate in both groups, it's unlikely to be caused by the vaccine and is more likely to be psychosomatic.
- chrisrogers 6y agoPsychosomatic, or the result of administering an IV shot, or environmental.
- ineedasername 6y agoI'm concerned that, given both effectiveness & willingness to get a vaccine, we may only experience incremental improvements in transmission rates. The flu vaccine is generally about 50% effective, and only about 50% of (Americans) say they will definitely or probably get a vaccine. If that holds, then combined, that would only cover 25% of the population. Well below herd immunity. Yes, it would be an improvement, but we should really be embarking on a heavy public awareness campaign that, once available (and assuming a low risk profile) that vaccination is the responsible and safe thing to do.
- atourgates 6y agoThe challenge is that we don't really know where the number of immune or semi-immune individuals comes in order to achieve "herd immunity" from Covid. Nature has a good article that goes into depth a bit here: https://www.nature.com/articles/d41586-020-02948-4 https://www.nature.com/articles/d41586-020-02948-4 Basically, there are reasonable estimates that the range could be anywhere from 20% - 70%. The effect also greatly depends on which portion of the population gets vaccinated. If (in an imaginary world) the most at-risk 50% of the population got vaccinated, we could reasonably expect Covid to actually become something like the flu. Finally, I expect this is something that'll gain acceptance over time. There are some not unreasonable factors that could cause people to be nervous about a Covid vaccine initially, that will be softened over time. Things like it being developed under the supervision of politicians who could be motivated to rush it out, or just being developed faster than any vaccine ever. Or, on the flipside, continued travel restrictions for individuals who haven't been vaccinated. Americans traveling to certain tropical countries have been required to get specific vaccines for years, I wouldn't be surprised if over the next few, travel to Europe or even Canada requires a Covid vaccine.
- Contax 6y agoTIL about the "jab" word in this context (English is not my first language). I thought the author had misspelled "lab".
- iamatworknow 6y agoI'm a native English speaker (American) and have thought it was odd for a few weeks that Reuters in particular likes to use the word "jab" for "vaccination". It's not commonly used that way in the US.
- NoodleIncident 6y agoIt's a holdover from print news media to use uncommon-but-short synonyms in headlines. There might be some benefit online as well, but since it's an established jargon/vernacular/dialect/etc of English, they probably just continue to use it out of habit.
- TillE 6y agoIt's extremely weird until you remember the American equivalent is "shot". I think the British media goes for the colloquial version a bit more, but it's hard to say for sure.
- iamatworknow 6y agoAh...yeah, I didn't even consider "shot" being similarly weird. I guess I'm just used to it.
- justnotworthit 6y agoIt's mine, and the one I study. I'm guessing it's slang for injection? Looking it up now... I sympathize with your pain of learning a new language (or system or whatever): It's hard to tell if it's a mistake on their part, a mistake on your part, some kind of regionalism, some kind poetry...
- Giorgi 6y agoI am assuming Pfizer will beat them then? They are expecting approval at the end of November if I recall it correctly and will probably push their stock
- Animats 6y agoThis is only one of 11 vaccines now in phase III efficacy tests.[1] Six vaccines already have "partial approval", but those are the ones in Russia and China, which may or may not be working, and the governments decided to try anyway. All of those provoke an immune response. Whether it's enough of the right immune response is found out in phase III testing. Something is probably going to work. The big question is how well. A 50% effective vaccine might be an overall lose - only half are protected but more than that abandon masks and social distancing. The Johnson and Johnson vaccine, if it works, is the easiest to use of the early leaders. One dose, and it doesn't need to be refrigerated to dry-ice temperatures like some of the others. The Merck/IAVI vaccine is only in phase I, but it's a pill. If that works and is highly effective, it will be possible to wipe the virus out worldwide in a second round of immunizations. [1] https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html https://www.nytimes.com/interactive/2020/science/coronavirus... (or https://archive.is/D6C68 https://archive.is/D6C68)
- Viliam1234 6y ago> A 50% effective vaccine might be an overall lose - only half are protected but more than that abandon masks and social distancing. I remember a similar argument being used against face masks. (That they are not perfect, and may cause harm by giving false sense of security.) Perhaps we should be more careful about perfect being the enemy of good.
- bastawhiz 6y agoThe availability of masks is far higher than vaccines, though. You can order a box of masks on the internet and have them same-day delivered to your home. The scarcity and logistics of delivering a vaccine once it becomes available are both factors that make the effectiveness that much more important.
- dan_quixote 6y agoAnd the use of both vaccine and masks may also be sufficient to lower the average covid vector just enough to tamp it down.
- phreeza 6y agoHow many people are in the trial, is the fact that two of the responses on this thread are from trial participants indicative of a bias towards nerds in the selection?
- dang 6y agoAll: don't miss that there are multiple pages of comments in this thread. That's what the More link at the bottom points to. Or click here: https://news.ycombinator.com/item?id=24894622&p=2 https://news.ycombinator.com/item?id=24894622&p=2
- alfiedotwtf 6y agoAnyone notice vaccine good news always drops when the Dow drops about 2%? Every time
- castis 6y agoMy understanding is that because stimulus packages are good for the stock market. When hopes are up about a vaccine, the possibility of a stimulus drops, hence the market comes down. I've only been following the market for about a year, but its a weird thing.
- bamboozled 6y agoWould some of the timing of this announcement have political motives? It's good news, but is this really news at this point?
- baron816 6y agoDoes anyone know why challenge trials haven’t been done? They should be much faster, right?
- tim333 6y agoIn other news they are hoping to ship it to NHS hospitals next week for emergency authorisation use in medics and old folk.